PMID: 7536619Mar 1, 1995Paper

Gene therapy for cystic fibrosis: a clinical perspective

Gene Therapy
Eric Alton, D M Geddes

Abstract

Since the isolation of the cystic fibrosis (CF) gene in 1989, the potential for gene therapy for this disease has existed. Although current treatments have resulted in a mean life expectancy of approximately 30 years, there is clearly a need for more effective therapy. A large number of studies have now assessed both in vitro and in vivo CFTR gene transfer into cell lines, animal models and most recently in CF subjects. Despite this rapid progress several difficulties remain including efficient in vivo gene transfer and the measurement of end-points to assess such gene transfer. This article reviews some of the clinically related aspects of gene therapy for CF.

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

The Journal of Gene Medicine
Jane DaviesEric Alton
Molecular Medicine Today
Jane DaviesEric Alton
Archives of Disease in Childhood
David K ArmstrongEric Alton
Comptes rendus des séances de la Société de biologie et de ses filiales
P Lehn
© 2021 Meta ULC. All rights reserved